A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1998
10/28/1998	EP0873128A1 Oral administration of effective amounts of forms of hyaluronic acid
10/28/1998	EP0873127A1 Anthelmintic macrocyclic lactone compositions
10/28/1998	EP0873125A1 Composition containing diosgenin
10/28/1998	EP0873124A1 A method of treating hypercholesterolemia and related disorders
10/28/1998	EP0873123A1 Inhibitors of protein isoprenyl transferases
10/28/1998	EP0873122A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma
10/28/1998	EP0873121A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of atrophy of skin and/or mucous membranes
10/28/1998	EP0873120A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms
10/28/1998	EP0873119A1 Use of the l-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer
10/28/1998	EP0873118A1 Transdermal administration of ropinirole and analogs thereof
10/28/1998	EP0873117A1 Hemoregulatory compounds
10/28/1998	EP0873116A1 Anti-inflammatory and infection protective effects of sesamin-based lignans
10/28/1998	EP0873111A1 Cosmetic and dermatological sunscreen formulations containing triazine derivatives and alkane carboxylic acids
10/28/1998	EP0873110A1 Improved hemostatic composition for treating gingival area
10/28/1998	EP0873051A1 Modulation of calcium channels
10/28/1998	EP0873050A1 Pharmaceutical compositions for prevention and treatment of ulcerative colitis
10/28/1998	EP0873049A1 Methods for enhanced virus-mediated dna transfer using molecules with virus- and cell-binding domains
10/28/1998	EP0817626B1 Use of fumagillol and derivatives thereof for preparing medicaments against intestinal infections
10/28/1998	EP0771187B1 Novel combination product comprising an antifungal agent and crotamiton as an antifungal activity enhancer and dermatological or cosmetic compositions comprising same
10/28/1998	EP0759742B1 Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods of use
10/28/1998	EP0754024B1 Inhibition of hair growth
10/28/1998	EP0752999B1 2,4-diphosphonoglutaric acid derivatives, methods of preparing such compounds and drugs containing them
10/28/1998	EP0716648B1 New 9-chloro-prostaglandin derivatives
10/28/1998	EP0715620B1 1-arylcycloalkyl sulphides, sulphoxides and sulphones for the treatment of depression, anxiety and parkinson's disease
10/28/1998	EP0712406B1 Condensed indole derivatives as 5-ht 4-receptor antagonists
10/28/1998	EP0701565B1 New prednisolone derivates
10/28/1998	EP0674651B1 Substituted 6-azaandrostenones
10/28/1998	EP0656887B1 Hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/28/1998	EP0649418B1 7-(2-aminoethyl)-benzothiazolones
10/28/1998	EP0634436B1 Sulfate of n-acetylneuraminic acid homopolymer, process for producing the same, anti-hiv drug containing said sulfate, method of treating aids with said sulfate, use of said sulfate for treating aids, and use of said sulfate for producing the drug
10/28/1998	EP0596917B1 Benzimidazole anthelmintics
10/28/1998	EP0593513B1 Tryptamine analogues, their synthesis and their use as 5-ht1-like receptors or 5-ht2 receptor agonistes
10/28/1998	EP0476016B1 CNS active 8-heterocyclyl-2-aminotetralin derivatives
10/28/1998	CN1197461A Truncated glial cell line-derived neurotrophic factor
10/28/1998	CN1197457A Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings
10/28/1998	CN1197456A Novel compsn. containing acid-labile benzimidazole and process for its prepn.
10/28/1998	CN1197453A 4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors
10/28/1998	CN1197452A Azetidinone derivatives for treatment of atherosclerosis
10/28/1998	CN1197450A Esters and amides as PLA2 inhibitors
10/28/1998	CN1197396A Copolymeric micelle drug compsn. and method for the prepn. thereof
10/28/1998	CN1197395A Compsn. containing nerve fibre reactivity modulating compound
10/28/1998	CN1197394A Compsns. and methods for catalyzing hydrolysis of HIV gp120
10/28/1998	CN1197393A Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof
10/28/1998	CN1197391A Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury
10/28/1998	CN1197388A Pharmaceutical compsn. for oral delivery
10/28/1998	CN1197387A Pharmaceutical compsns. of conjugated estrogens and methods for their use
10/28/1998	CN1197077A Nucleic acid construct for cell cycle regulated expression of structural genes
10/28/1998	CN1197076A Steroid compounds having contraceptive and anti-osteoporosis activity
10/28/1998	CN1197075A New secomacrolides from class of erythromycins and process for their preparation
10/28/1998	CN1197072A New N-aryl piperidine compounds, process for their preparation and pharmaceutical compositions containing them
10/28/1998	CN1197067A New naphthylpiperazine derivatives
10/28/1998	CN1197059A Substituted amino compounds and their use as substances having analgesic effect
10/28/1998	CN1196955A Thebaica giving-up vaccinum for man
10/28/1998	CN1196942A Compound Chinese and western medicinal compsn. for treating 'down elimination' diabetes
10/28/1998	CN1196941A Compound Chinese and western medicinal compsn. for treating 'medium elimination' diabetes
10/28/1998	CN1196940A Compound Chinese and western medicinal compsn. for treating 'upper elimination' diabetes
10/28/1998	CN1196934A External-use skeleton powder and its prepn. method
10/28/1998	CN1196933A External-use drops for ear and its prepn. method
10/28/1998	CN1196932A Oral application of (+)-0-demethyltramadol as pain-killing drug
10/28/1998	CN1196930A Drug delivery system for twor or more active substance
10/28/1998	CN1040441C Process for prepn. of 3-exomethylenecepham derivatives
10/28/1998	CN1040440C Process for preparing dehydrocycloclausenamide derivatives
10/28/1998	CN1040438C One-pot process for preparing sulfur propyl ergoline
10/28/1998	CN1040436C Method for prepn. of compound as 5-hydroxy tryptamine receptor inhibitor
10/28/1998	CN1040435C Trisubstituted biphenyls, its prepn. and applications in medicines
10/28/1998	CN1040434C 杂二环化合物 Heterobicycle compound
10/28/1998	CN1040433C Azole compounds, their prodn. and use
10/28/1998	CN1040432C Spiro piperdines derivatives and its prepn. and applications
10/28/1998	CN1040423C Enzymatic resolution of endo bicycle [2.2.1] heptan-2-ol and derived pharmaceutical agents
10/28/1998	CN1040395C External-use medicine with skin care and beautifying function
10/28/1998	CN1040394C Anti-microbe compsn. for dental use and toothbrush coated the same
10/28/1998	CA2231746A1 A human sodium dependent phosphate transporter (ipt-1)
10/27/1998	US5827937 Steric hindrance to activate partially crosslinked polysaccharide prior to final crosslinking in non-sterically hindered conditions to form viscoelasic gel which does not swell in water
10/27/1998	US5827925 Polymeric material bonded to drug through ph-sensitive cleavable covalent bond
10/27/1998	US5827900 Administering lycopene
10/27/1998	US5827898 Use of bisphenolic compounds to treat type II diabetes
10/27/1998	US5827897 Insulin-resistance in a mammal treated by administering a synergistic mixture of a retinoid and a fatty acid; antidiabetic agents
10/27/1998	US5827896 Pinitol and derivatives thereof for the treatment of metabolic disorders
10/27/1998	US5827895 Inhibiting the infection of staphylococcus or mycobacterium by administering a cyclohexane-diketone-diols; anticarcinogenic agents
10/27/1998	US5827894 Antitumor agents, antigrowth agents for treatment of psoriasis, insecticides
10/27/1998	US5827893 Mechanical and pharmacological therapies to treat cardiac arrest
10/27/1998	US5827892 Treatment and prevention of atherosclerosis
10/27/1998	US5827891 For treatment of aids, blocking replication of hiv virus
10/27/1998	US5827890 Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors
10/27/1998	US5827888 Perinatal treatment of a fetus to avoid oxygen deprivation
10/27/1998	US5827887 Biphenyl compounds
10/27/1998	US5827886 Reduced glutathione, selenoamino acid, anesthetic
10/27/1998	US5827885 Methods of treating animals to maintain or increase CD-4 and CD-8 cell populations
10/27/1998	US5827884 Using an acid dispersed in a liquid carrier and determining the degree of coverage by visual observation; elimination of the use of ultraviolet radiation
10/27/1998	US5827883 Topical drug delivery; side effect reduction
10/27/1998	US5827882 Method of using ethyl pyruvate for treating wrinkles
10/27/1998	US5827881 Diesters of carbonic acid endowed with antiviral and anti-inflammatory activity
10/27/1998	US5827880 Salen-metal complexes
10/27/1998	US5827878 For inducing differentiation of leukemia cells; anticarcinogenic agents
10/27/1998	US5827876 Inhibition of bone loss by 3-(4-acrylamidobenzoyl) benzo b!-thiophenes
10/27/1998	US5827874 Rheumatic, nonrheumatic and postoperative posttraumatic pain
10/27/1998	US5827873 Alzheimer's disease
10/27/1998	US5827871 Medicaments 1,2,3,4-tetrahydrocarbazoles and 5-HT1 agonist use thereof
10/27/1998	US5827869 Substituted biphenyl isoxazole sulfonamides
10/27/1998	US5827868 Prostaglandin analogs

1 ... 6589 6590 6591 6592 6593 6594 6595 6596 6597 6598 6599 6600 6601 6602 6603 6604 6605 6606 6607 6608 6609 ... 7860